Dr Dorairaj Prabhakaran is currently Vice President ( Research and Policy) and Director, Centre for Control of Chronic Conditions, PHFI.Dr Shuchi Anand M.D. M.S. is Director of the Center for Tubulointerstitial Kidney Disease and Assistant Professor of Medicine (Nephrology) at Stanford University.Prof.K. Srinath Reddy is the President, Public Health Foundation of India (PHFI) and formerly headed the Department of Cardiology at All India Institute of Medical Sciences (AIIMS).

• Chapter 1 Cardiovascular Diseases WorldwideChapter 2 Cardiovascular diseaseChapter 3 Concept of Risk and Risk factorsChapter 4 Concepts in PreventionChapter 5 Risk Factors5.1 – Cardiovascular Disease Risk Factors5.2 – Tobacco5.3 Diet5.4 Physical Activity5.5 Cardiovascular Disease, Overweight and Obesity: Shared Strategies for Prevention and Management5.6 Alcohol5.7 Public Health approaches to prevention and management of hypertension in LMICs5.8 Diabetes5.9 Public Health and Clinical Approaches to Dyslipidemia ManagementChapter 6 Emerging and life course factors in CVDChapter 7 Social determinants of cardiovascular diseasesChapter 8 How do we frame public health policies?Chapter 9 Public Health Policies for Prevention and Control of Cardiovascular Diseases (CVDs)Chapter 10 Situational Analysis of Health Policies for Cardiovascular Disease (CVD) Prevention and ControlChapter 11 Role of Surveillance Systems and Health Observatories for intelligent public health approach to cardiovascular diseasesChapter 12 Health Systems Interventions for Preventing CVD in Low and Middle-income CountriesChapter 13 Advocacy and Health PromotionChapter 14 Digital Health and Cardiovascular disease: Current Status and Future DirectionsChapter 15 Public Health Approaches to Rheumatic Heart Disease Prevention and ManagementChapter 16 Cost-Effectiveness Analysis: Methods, Innovations and ApplicationsChapter 17 Universal health coverage for better cardiovascular disease outcomes in LMICs: Focus on quality, not just coverageChapter 18 Monitoring and Evaluation of Cardiovascular Diseases Prevention programs

Dr Dorairaj Prabhakaran is currently Vice President ( Research and Policy) and Director, Centre for Control of Chronic Conditions, PHFI.Dr Shuchi Anand M.D. M.S. is Director of the Center for Tubulointerstitial Kidney Disease and Assistant Professor of Medicine (Nephrology) at Stanford University.Prof.K. Srinath Reddy is the President, Public Health Foundation of India (PHFI) and formerly headed the Department of Cardiology at All India Institute of Medical Sciences (AIIMS).

• Chapter 1 Cardiovascular Diseases WorldwideChapter 2 Cardiovascular diseaseChapter 3 Concept of Risk and Risk factorsChapter 4 Concepts in PreventionChapter 5 Risk Factors5.1 – Cardiovascular Disease Risk Factors5.2 – Tobacco5.3 Diet5.4 Physical Activity5.5 Cardiovascular Disease, Overweight and Obesity: Shared Strategies for Prevention and Management5.6 Alcohol5.7 Public Health approaches to prevention and management of hypertension in LMICs5.8 Diabetes5.9 Public Health and Clinical Approaches to Dyslipidemia ManagementChapter 6 Emerging and life course factors in CVDChapter 7 Social determinants of cardiovascular diseasesChapter 8 How do we frame public health policies?Chapter 9 Public Health Policies for Prevention and Control of Cardiovascular Diseases (CVDs)Chapter 10 Situational Analysis of Health Policies for Cardiovascular Disease (CVD) Prevention and ControlChapter 11 Role of Surveillance Systems and Health Observatories for intelligent public health approach to cardiovascular diseasesChapter 12 Health Systems Interventions for Preventing CVD in Low and Middle-income CountriesChapter 13 Advocacy and Health PromotionChapter 14 Digital Health and Cardiovascular disease: Current Status and Future DirectionsChapter 15 Public Health Approaches to Rheumatic Heart Disease Prevention and ManagementChapter 16 Cost-Effectiveness Analysis: Methods, Innovations and ApplicationsChapter 17 Universal health coverage for better cardiovascular disease outcomes in LMICs: Focus on quality, not just coverageChapter 18 Monitoring and Evaluation of Cardiovascular Diseases Prevention programs